about
The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury.Neuroprotective effect of resveratrol against methamphetamine-induced dopaminergic apoptotic cell death in a cell culture model of neurotoxicity.A simple magnetic separation method for high-yield isolation of pure primary microgliaAntiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cord.Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's DiseaseProteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammationProtein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration.Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation.p73 gene in dopaminergic neurons is highly susceptible to manganese neurotoxicity.Motor deficits associated with Huntington's disease occur in the absence of striatal degeneration in BACHD transgenic mice.The Ketone Body β-Hydroxybutyrate Does Not Inhibit Synuclein Mediated Inflammasome Activation in Microglia.An overview of sleep and circadian dysfunction in Parkinson's disease.Chronic helminth infection perturbs the gut-brain axis, promotes neuropathology and alters behaviour.Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytesInflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in miceElevation of the terminal complement activation products C5a and C5b-9 in ALS patient bloodInflammasomes in CNS Diseases
P50
Q34473321-0B9D60E4-E9FD-48C1-A5BA-29B0657E4F40Q35107878-385CC365-0087-4A10-82D7-927C60CCE3D8Q35492364-D00A3596-D1D3-4148-9C16-8A77AFCEF00AQ35822338-A9AE2597-03CA-42AA-841A-22020884B36EQ35829484-BEDE496B-BD11-4406-A3A5-25F7094BA164Q36165760-BC1D2AB7-06F4-43BF-9DCA-CF9528513EAAQ37198050-DDA444DA-EED1-4D38-9023-DA76492A080CQ37329938-82325ED9-C50C-4C0E-86B4-71CC95433FB2Q40067295-BC73067D-4FF1-4FA4-B320-92281E823B7FQ42492256-1521E401-A2F7-40CB-A430-21885BBDD2EDQ45293567-7BF8FB44-773D-4A1C-9FAD-DE33D048FE4FQ47912686-2C1FBED9-F992-4183-BC80-3022FC5B6F7DQ50533591-8E2C280F-679F-472B-A0DE-A62900E3757EQ50535701-B17E3F7E-B42A-4F7C-A838-57AC3DC80605Q57112432-005FC07B-7501-4527-A00D-6BEF84B59A9EQ58091986-7CE7B4BA-62D8-4517-A583-4882EC5F407BQ60324739-17180DCA-4630-4610-BDC4-C482ACFB7A99Q63916935-ECB3C399-EA3E-4034-ABD2-6DAF1C3AAF80
P50
description
researcher ORCID ID = 0000-0003-2478-4607
@en
wetenschapper
@nl
name
Richard Gordon
@ast
Richard Gordon
@en
Richard Gordon
@es
Richard Gordon
@nl
type
label
Richard Gordon
@ast
Richard Gordon
@en
Richard Gordon
@es
Richard Gordon
@nl
prefLabel
Richard Gordon
@ast
Richard Gordon
@en
Richard Gordon
@es
Richard Gordon
@nl
P1153
56643772900
P31
P496
0000-0003-2478-4607